| Pharmaceutical active ingredients: |
| Levothyroxine Sodium |
| Available forms, composition and doses of Cynocuatro: |
| Tablets; Oral; Levothyroxine Sodium 100 mcgTablets; Oral; Levothyroxine Sodium 25 mcgTablets; Oral; Levothyroxine Sodium 50 mcg |
| Cynocuatro medical category: |
| Human:Thyroid agentsThyroid hormones |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| H03AA01 - Levothyroxine Sodium |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Grossman Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cyndet | Benzalkonium Chloride | M-Chem Industries |
| Cyne | Butamirate Citrate | Novartis |
| Cynobac | Folic Acid; Lactobacillus Sporogenes; Vitamin B12 | Strassenburg Pharmaceuticals |
| Cynobac Tender | Folic Acid; Lactobacillus Sporogenes; Vitamin B12 | Strassenburg Pharmaceuticals |
| Cynobal | Vitamin B12 | Unidentified Pharmaceutical Company |
| Cynomel | Liothyronine Sodium | Sanofi-Aventis; Enila Laboratorio; Grossman Laboratorios; Institute of Pharmaceutical Research and Technology |
| Cynomycin | Minocycline Hydrochloride | Wyeth |
| Cynoplus | Levothyroxine Sodium; Liothyronine Sodium | Grossman Laboratorios |
| Cynosal | Acetaminophen; Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | Lejal Laboratories |
| Cynosal Drops | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | Lejal Laboratories |